← All indications
Keloid
A sharply elevated, irregularly shaped, progressively enlarging scar resulting from formation of excessive amounts of collagen in the dermis during connective tissue repair. It is differentiated from a hypertrophic scar (CICATRIX, HYPERTROPHIC) in that the former does not spread to surrounding tissues.
Subtype terms (1)
More specific conditions that are subtypes of Keloid in the MeSH hierarchy.
- Acne Keloid
4 drugs approved
Drugs by status
Phase 4 trials (14)
Phase 3 trials (3)
Phase 2 trials (13)
Phase 1 trials (5)
Other trials (2)
Organizations
Organization Involved with Phase 4 Indications (7)
Organization Involved with Phase 3 Indications (4)
Organization Involved with Phase 2 Indications (15)
- Novartis
- Virginia Clinical Research, Inc.
- miRagen Therapeutics, Inc.
- Capstone Therapeutics
- RenovoRx
- Tirgan, Michael H., M.D.
- University of Pennsylvania
- Makerere University
- Icahn School of Medicine at Mount Sinai
- RXi Pharmaceuticals
- Keloid Research Foundation
- Dermatology Consulting Services, High Point NC
- TKL Research
- Body Aesthetic Plastic Surgery and Skincare Center, St Louis, Missori
- Prodia StemCell Indonesia
Organization Involved with Phase 1 Indications (3)
Organization Involved with Other Experimental Indications (5)